In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biopharmaceuticals Beyond The Drug: Changing Pharma's Value Proposition

Executive Summary

Responding to a convergence of a changing market and shifts in technology, pharmaceutical companies are exploring ways to enhance the value of their products and find new opportunities beyond their core molecule-driven businesses.
Advertisement

Related Content

Merck's Capital Idea: Industry's Latest Push to Strengthen VC Ties
Sanofi/Genzyme: Emblematic of What Big Pharma's Buying Now
Personalizing Patient Care:Sanofi Recasts Its Diabetes Efforts
The Shake Up At Endo Pharma
The Shake Up At Endo Pharma
Personalizing Patient Care:Sanofi Recasts Its Diabetes Efforts
Sanofi-AgaMatrix Deal a Harbinger
Sanofi-AgaMatrix Deal a Harbinger
JJDC Strategy Emphasizes the J & the J
JJDC Strategy Emphasizes the J & the J

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV003696

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel